Close Menu

This article has been updated with information from the Wadsworth Center of the New York State Department of Health.

NEW YORK – Labs and companies across the world are betting on alternative specimen types for COVID-19 testing – such as saliva, nasal swabs, or oral solution – to increase the speed and convenience of sample collection, aiming to overcome one of the challenges in rapidly scaling up testing efforts.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.